株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

尿検査:パイプライン分析

Urine Analysis - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 341583
出版日 ページ情報 英文 95 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
尿検査:パイプライン分析 Urine Analysis - Medical Devices Pipeline Assessment, 2019
出版日: 2019年11月01日 ページ情報: 英文 95 Pages
概要

当レポートでは、世界各国の企業・医療機関などで開発が進められている尿検査のパイプライン製品情報について分析しており、治験と製品開発の進行状況、段階別・セグメント別・国 (地域) 別の動向、企業と製品の詳細情報、最近の製品開発および業界の動向などの情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 尿検査の概要

第3章 開発中の製品

  • 尿検査 - 開発段階別のパイプライン製品
  • 尿検査 - セグメント別のパイプライン製品
  • 尿検査 - 国 (地域) 別のパイプライン製品
  • 尿検査 - 規制別のパイプライン製品
  • 尿検査 - 認証時期別 (推定) のパイプライン製品
  • 尿検査 - 現在進行中の治験

第4章 尿検査 - 開発中のパイプライン製品:企業別

  • 尿検査企業 - 開発段階別のパイプライン製品
  • 尿検査 - 開発段階別のパイプライン製品

第5章 尿検査企業と製品の概要

  • Analyticon Biotechnologies AG
  • Arkray, Inc.
  • Biosense Technologies Pvt Ltd.
  • California Pacific Medical Center Research Institute
  • Erba Diagnostics, Inc.
  • Imagnus Biomedical Inc.
  • Imperial College London
  • IRIS International, Inc.
  • LifeAssays AB
  • Roche Diagnostics International Ltd.
  • Scanadu HQ
  • Shenzhen Genius Electronics Co., Ltd.
  • Siemens Healthcare Diagnostics Inc.
  • Stanford University
  • Svenska Cellulosa Aktiebolaget
  • シスメックス
  • Teco Diagnostics
  • University of California, San Francisco
  • University of Kentucky
  • University of Maryland, Baltimore

第6章 尿検査 - 最近の動向

第7章 付録

図表

List of Tables

  • Table 1: Urine Analysis - Pipeline Products by Stage of Development 8
  • Table 2: Urine Analysis - Pipeline Products by Segment 9
  • Table 3: Urine Analysis - Pipeline Products by Territory 10
  • Table 4: Urine Analysis - Pipeline Products by Regula

List of Figures

  • Figure 1: Urine Analysis - Pipeline Products by Stage of Development 8
  • Figure 2: Urine Analysis - Pipeline Products by Segment 9
  • Figure 3: Urine Analysis - Pipeline Products by Territory 10
  • Figure 4: Urine Analysis - Pipeline Products by R
目次
Product Code: GDME0806EPD

GlobalData's Medical Devices sector report, "Urine Analysis - Medical Devices Pipeline Assessment, 2019" provides an overview of Urine Analysis currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Urine Analysis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Urine Analysis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Urine Analysis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Urine Analysis Overview 7

3 Products under Development 8

  • 3.1 Urine Analysis - Pipeline Products by Stage of Development 8
  • 3.2 Urine Analysis - Pipeline Products by Segment 9
  • 3.3 Urine Analysis - Pipeline Products by Territory 10
  • 3.4 Urine Analysis - Pipeline Products by Regulatory Path 11
  • 3.5 Urine Analysis - Pipeline Products by Estimated Approval Date 12
  • 3.6 Urine Analysis - Ongoing Clinical Trials 13

4 Urine Analysis - Pipeline Products under Development by Companies 14

  • 4.1 Urine Analysis Companies - Pipeline Products by Stage of Development 14
  • 4.2 Urine Analysis - Pipeline Products by Stage of Development 15

5 Urine Analysis Companies and Product Overview 16

  • 5.1 Analyticon Biotechnologies AG Company Overview 16
    • 5.1.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Arkray Inc Company Overview 21
    • 5.2.1 Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Biosense Technologies Pvt Ltd. Company Overview 22
    • 5.3.1 Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Bisu Inc Company Overview 23
    • 5.4.1 Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.5 California Pacific Medical Center Research Institute Company Overview 24
    • 5.5.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.6 First Light Diagnostics Inc Company Overview 25
    • 5.6.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.7 Healthy io Ltd Company Overview 26
    • 5.7.1 Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.8 Imperial College London Company Overview 28
    • 5.8.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.9 IRIS International Inc Company Overview 29
    • 5.9.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.10 LifeAssays AB Company Overview 30
    • 5.10.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.11 NTBIO Diagnostics Inc Company Overview 31
    • 5.11.1 NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.12 Sebia SA Company Overview 32
    • 5.12.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.13 Siemens Healthineers AG Company Overview 34
    • 5.13.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.14 Stanford University Company Overview 35
    • 5.14.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.15 Sysmex Corp Company Overview 36
    • 5.15.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.16 Teco Diagnostics Company Overview 38
    • 5.16.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.17 Trinity College Dublin Company Overview 39
    • 5.17.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.18 University of Kentucky Company Overview 40
    • 5.18.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview 40

6 Urine Analysis- Recent Developments 41

  • 6.1 Sep 25, 2019: UK urine test to detect early-stage pancreatic cancer starts clinical study 41
  • 6.2 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement 42
  • 6.3 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 42
  • 6.4 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 43
  • 6.5 Aug 14, 2019: Nymox Pharmaceutical: financial Results for the three and six months ended June 30, 2019 44
  • 6.6 Aug 06, 2019: Blood clotting proteins discovered as biomarkers of Lupus Nephritis 48
  • 6.7 Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results 49
  • 6.8 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 50
  • 6.9 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 52
  • 6.10 Jul 24, 2019: Delaware District Court grants Bio-Rad's Motion for Permanent Injunction against 10X Genomics 52
  • 6.11 Jul 17, 2019: Healthy.io's at-home, smartphone-based urinalysis test available in boots pharmacies across the U.K. 53
  • 6.12 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 54
  • 6.13 Jul 11, 2019: Study finds Healthy.io's At-Home, smartphone-based urinalysis feasible, preferred, and easy-to-use for women in prenatal care 55
  • 6.14 May 27, 2019: Sysmex and Osaka University sign comprehensive collaboration agreement to foster innovation in the healthcare field 56
  • 6.15 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab" 57
  • 6.16 May 15, 2019: Nymox Pharmaceutical: Financial result for three months ended March 31, 2019 57
  • 6.17 May 08, 2019: Bio-Rad reports first quarter 2019 financial results 62
  • 6.18 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 64
  • 6.19 Apr 29, 2019: Urine test could prevent cervical cancer 65
  • 6.20 Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer 67
  • 6.21 Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer 67
  • 6.22 Apr 01, 2019: Mologic expands US and UK operations 67
  • 6.23 Mar 19, 2019: Researchers develop new test for prostate cancer 68
  • 6.24 Mar 19, 2019: Nymox Pharmaceutical names Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls 69
  • 6.25 Mar 13, 2019: Nymox announces appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for company's manufacturing operations 70
  • 6.26 Mar 13, 2019: EKF Diagnostics Holdings: Final results 70
  • 6.27 Mar 07, 2019: Mindray signs patient safety movement's open data pledge & becomes 90th company to join to improve patient safety 76
  • 6.28 Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results 77
  • 6.29 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 79
  • 6.30 Feb 07, 2019: New home test for kidney damage shows promising results 80
  • 6.31 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices 81
  • 6.32 Jan 03, 2019: Bio-Rad finance chief to retire 82
  • 6.33 Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories 82
  • Reference Centre 90

7 Appendix 92

  • 7.1 Methodology 92
  • 7.2 About GlobalData 95
  • 7.3 Contact Us 95
  • 7.4 Disclaimer 95
Back to Top